3d-Medicines on Bioeconhttps://en.bioecon.ru/companies/3d-medicines/Recent content in 3d-Medicines on BioeconHugoen-USMon, 20 Jul 2026 16:10:46 +0700Companion diagnostics platformshttps://en.bioecon.ru/technology/companion-diagnostics-platforms/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/companion-diagnostics-platforms/Tissue-based immunohistochemistry (IHC) and FISH platforms that determine whether a specific patient is eligible for a specific targeted therapy, sold and regulated as a companion diagnostic (CDx) tied directly to a drug label — distinct from blood-based liquid-biopsy CDx: Ventana/Roche Tissue Diagnostics, Agilent Dako and Myriad Genetics in the US, 3D Medicines in China, and MedGenome in India.